Drugs that contain Levodopa
1. Inbrija patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8628754 | ACORDA | Highly efficient delivery of a large therapeutic mass aerosol |
Jun, 2020
(3 years ago) | |
| US6921528 | ACORDA | Highly efficient delivery of a large therapeutic mass aerosol |
Jun, 2020
(3 years ago) | |
| US6514482 | ACORDA | Pulmonary delivery in treating disorders of the central nervous system |
Sep, 2020
(3 years ago) | |
| US6613308 | ACORDA | Pulmonary delivery in treating disorders of the central nervous system |
Sep, 2020
(3 years ago) | |
| US6979437 | ACORDA | Pulmonary delivery in treating disorders of the central nervous system |
Sep, 2020
(3 years ago) | |
| US7146978 | ACORDA | Inhalation device and method |
Apr, 2021
(3 years ago) | |
| US6858199 | ACORDA | High efficient delivery of a large therapeutic mass aerosol |
Nov, 2021
(2 years ago) | |
| US7556798 | ACORDA | Highly efficient delivery of a large therapeutic mass aerosol |
Nov, 2021
(2 years ago) | |
| US7384649 | ACORDA | Particulate compositions for pulmonary delivery |
Nov, 2022
(1 year, 5 months ago) | |
| US9155699 | ACORDA | Pulmonary delivery for levodopa |
Mar, 2023
(1 year, 1 month ago) | |
| US8586093 | ACORDA | Pulmonary delivery for levodopa |
Mar, 2023
(1 year, 1 month ago) | |
| US8404276 | ACORDA | Pulmonary delivery for levodopa |
Mar, 2023
(1 year, 1 month ago) | |
| US7182961 | ACORDA | Particulate compositions for pulmonary delivery |
Feb, 2024
(2 months ago) | |
| USRE43711 | ACORDA | Pulmonary delivery for levodopa |
Feb, 2029
(4 years from now) | |
| US8945612 | ACORDA | Capsules containing high doses of levodopa for pulmonary use |
Nov, 2032
(8 years from now) | |
| US8545878 | ACORDA | Capsules containing high doses of levodopa for pulmonary use |
Nov, 2032
(8 years from now) | |
| US9393210 | ACORDA | Capsules containing high doses of levodopa for pulmonary use |
Nov, 2032
(8 years from now) | |
| US8685442 | ACORDA | Capsules containing high doses of levodopa for pulmonary use |
Nov, 2032
(8 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | Dec 21, 2021 |
Market Authorisation Date: 21 December, 2018
Treatment: Intermittent treatment of off episodes in patients with parkinson's disease treated with carbidopa/levodopa by inhalation of levodopa powder particles through a single breath activated step; Intermitt...
Dosage: POWDER;INHALATION
More Information on Dosage
INBRIJA family patents
